← back to search

Qiuqing Wang

Cleveland Clinic · US
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Cardiomyopathy and Myosin Studies, Inflammatory mediators and NSAID effects, Cardiovascular Function and Risk Factors, and Cardiac Structural Anomalies and Repair.
h-index
17
citations
2,794
works
32
NIH funding
primary concept
Medicine
email

Recent publications

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
New England Journal of Medicine 2025cited by 46position: middledoi
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology 2025cited by 10position: middledoi
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology 2025cited by 9position: middledoi
Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial
Circulation Cardiovascular Imaging 2024cited by 35position: middledoi
Cardiovascular Safety of Testosterone-Replacement Therapy
New England Journal of Medicine 2023cited by 408position: middledoi
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study
Circulation Cardiovascular Imaging 2022cited by 73position: middledoi
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial
The Lancet Rheumatology 2021cited by 68position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Steven E. Nissen · Esperion Therapeutics (United States)4 papers (2022–2025)Milind Y. Desai · Cedars-Sinai Medical Center3 papers (2022–2025)Anjali Owens · Sequoia (United States)3 papers (2022–2025)Kathy Wolski · Cleveland Clinic3 papers (2022–2025) · 2 papers (2025–2025)Theodore P. Abraham · Baim Institute for Clinical Research2 papers (2025–2025)Olga Azevedo · Australian National University2 papers (2025–2025)Perry Elliott · Great North Children's Hospital2 papers (2025–2025)Iacopo Olivotto · Harvard University2 papers (2025–2025) · 2 papers (2025–2025)Benjamin Meder · Sequoia (United States)2 papers (2025–2025) · 2 papers (2025–2025)Victoria Florea · Bristol-Myers Squibb (United States)2 papers (2025–2025)Nicolas Verheyen · Medical University of Graz2 papers (2025–2025)Pablo García‐Pavía · Hospital La Paz Institute for Health Research2 papers (2025–2025)Renato D. Lópes · Alnylam Pharmaceuticals (United States)2 papers (2025–2025)Wael A. Jaber · Cleveland Clinic2 papers (2022–2025)Michael C. Snabes · AbbVie (United States)1 papers (2023–2023) · 1 papers (2025–2025)Xue Li · Wuhan Institute of Technology1 papers (2023–2023)